The Asco Post

Today in Oncology

Current News from the World of Oncology Last Updated: Monday, January 26, 2015 11:02:04 AM

Featured Columnists

What Is a Physician? Call a Spade a Spade Chandrakanth Are, MBBS, FRCS, FACS  

Transplants for AML in First Remission: A Great Leap Forward, Sideways, or Backward? Robert Peter Gale, MD, PhD, DSc(hc), FACP, Hillard M. Lazarus, MD, FACP, and Peter H. Wiernik, MD, FACP, FASCO  

When Should We Stop Prescribing? John F. Smyth, MD  

More Featured Columnists

Expert Opinions

Colorectal Cancer 2015  

Breast Health Global Initiative Tackles Third-World Health Care  

Incorporating Physical Medicine and Rehabilitation Into Palliative Care  

More Expert Opinions

Meeting News

Carfilzomib-Based Triplet Yields ‘Unprecedented’ Duration of Remission in ... Ovarian Suppression Plus Hormonal Therapy May Be Practice-Changing in Prem... Brentuximab Vedotin Added to Standard Therapy for Advanced-Stage Hodgkin ... Post-Transplant Brentuximab Vedotin Improved Progression-Free Survival in... More Meeting News

Journal Spotlight

Vitamin D Protects Against Colorectal Cancer by Boosting the Immune System Nivolumab Improves Outcomes vs Dacarbazine in Previously Untreated Advance... Coupling Head and Neck Cancer Screening and Lung Cancer Scans Could Improv... No Benefit of Adding Lapatinib to Fulvestrant in Hormone Receptor–Positive... More Journal Spotlights

Health-Care Policy

Molecular Pathologists vs the FDA: Proposed Regulation of Laboratory-Developed Tests Sparks Debate ASCO and AACR Call for Regulation of E-Cigarettes and Other Electronic Nicotine Delivery Systems CMS Issues Preliminary Decision to Cover Annual Lung Cancer Screening Policy Issues in Molecularly Targeted Therapy: The Science, the Money, the Applications More Health-care Policy

Drugs & Regimens

Nilotinib With Low-Intensity Chemotherapy Useful in Elderly Patients With Philadelphia Chromosome–Positive ALL Neoadjuvant Therapy in Triple-Negative Breast Cancer: Impact of Subtype Pembrolizumab Holds Promise in Breast Cancer, Early Studies Suggest BOLERO-1: Everolimus Plus Trastuzumab/Paclitaxel Misses the Mark in First-Line HER2-Positive Advanced Breast Cancer More Drugs & Regimens

Oncology Worldwide

Breast Health Global Initiative Tackles Third-World Health Care Breaking the Silence About Breast Cancer in the Arab World Despite Growing Awareness, the Global Crisis of Untreated Cancer Pain Persists Effective Prevention Measures Urgently Needed to Prevent Global Cancer Crisis More Oncology Worldwide

Patient's Corner

Ovarian Cancer Has Taught Me to Be Fearless Beating the Odds Lessons From Cancer Social Media Is Helping Me Cope With Cancer More Patient's Corner
More on Twitter